Marker Therapeutics Inc (MRKR)vsRevolution Medicines Inc (RVMD)
MRKR
Marker Therapeutics Inc
$1.17
+1.74%
HEALTHCARE · Cap: $20.67M
RVMD
Revolution Medicines Inc
$205.11
+0.66%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Marker Therapeutics Inc generates 378% more annual revenue ($3.55M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -245.5%. RVMD earns a higher WallStSmart Score of 24/100 (F).
MRKR
Avoid22
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -77.0% — below average capital efficiency
Trading at 16.9x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRKR
The strongest argument for MRKR centers on Price/Book.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : MRKR
The primary concerns for MRKR are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
MRKR profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
MRKR carries more volatility with a beta of 1.51 — expect wider price swings.
MRKR is growing revenue faster at -51.0% — sustainability is the question.
MRKR generates stronger free cash flow (-4M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 22/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Marker Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?